Australia markets closed

JCR Pharmaceuticals Co., Ltd. (4552.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
584.00+1.00 (+0.17%)
At close: 03:15PM JST
Currency in JPY

Valuation measures4

Market cap (intra-day) 72.76B
Enterprise value 77.76B
Trailing P/E 13.27
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.71
Price/book (mrq)1.42
Enterprise value/revenue 1.81
Enterprise value/EBITDA 10.33

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-54.68%
S&P500 52-week change 325.22%
52-week high 31,567.00
52-week low 3522.00
50-day moving average 3682.58
200-day moving average 31,016.82

Share statistics

Avg vol (3-month) 3760.74k
Avg vol (10-day) 3514.12k
Shares outstanding 5124.8M
Implied shares outstanding 6126.52M
Float 873.39M
% held by insiders 143.26%
% held by institutions 115.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 420
Forward annual dividend yield 43.43%
Trailing annual dividend rate 320.00
Trailing annual dividend yield 33.43%
5-year average dividend yield 40.95
Payout ratio 445.54%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 24:1
Last split date 330 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.85%
Operating margin (ttm)-3.03%

Management effectiveness

Return on assets (ttm)4.77%
Return on equity (ttm)10.17%

Income statement

Revenue (ttm)42.87B
Revenue per share (ttm)343.54
Quarterly revenue growth (yoy)19.70%
Gross profit (ttm)N/A
EBITDA 10.73B
Net income avi to common (ttm)5.51B
Diluted EPS (ttm)43.90
Quarterly earnings growth (yoy)70.10%

Balance sheet

Total cash (mrq)18.76B
Total cash per share (mrq)150.28
Total debt (mrq)23.3B
Total debt/equity (mrq)41.26%
Current ratio (mrq)1.91
Book value per share (mrq)450.11

Cash flow statement

Operating cash flow (ttm)9.31B
Levered free cash flow (ttm)4.25B